Company / Goodwill
ResMed Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$3.0B
FY2025
5-year range
$1.9B / $3.0B
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#38 of 141
Health Care
What the data says
At $3.0B, ResMed's goodwill ranks #38 of 141 in the Health Care sector. Goodwill has increased for 9 consecutive years, from $1.1B in FY2016 to $3.0B in FY2025.
Based on SEC 10-K filings.
$3.0B in FY2025 with a 5-year CAGR of +10.0%.
Improved from $2.8B to $3.0B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +16.3%
- 5-Year CAGR
- +10.0%
- 10-Year CAGR
- -
Sector benchmark
#38 of 141 in Health CareTop 27% of 141This company $3.0B Sector average $5.4B
▼
-43.4% below sector average
Key checks
Key Insights
- ResMed's goodwill has grown for 9 consecutive years.
- 5-year CAGR of +10.0%, indicating consistent growth.
- In FY2025, goodwill increased 7.2% year-over-year.
- Ranks #38 out of 141 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0B | +7.2% |
| FY2024 | $2.8B | +2.6% |
| FY2023 | $2.8B | +43.1% |
| FY2022 | $1.9B | +0.4% |
| FY2021 | $1.9B | +2.0% |
| FY2020 | $1.9B | +1.8% |
| FY2019 | $1.9B | +73.7% |
| FY2018 | $1.1B | +0.4% |
| FY2017 | $1.1B | +0.5% |
| FY2016 | $1.1B | +300.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026